Search results for "Streamline" in Articles / App Notes
								 					Article
				
				Framing Biopharma Success in 2016
								
	Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016. 
	By Rita C. Peters 
	The US biopharmaceutical industry turned a new page in 2015 when…								
								 					Article
				
				Biopharma Advances Demand Specialized Expertise
								
	Jun 15, 2015 
	
	By BioPharm International Editors 
	
	BioPharm International eBooks 
	
	Volume 28, Issue 13 
Contract service providers share insights on biopharma market developments and the impl…								
								 					Article
				
				Continuous Manufacturing: A Changing Processing Paradigm
								Other advantages of continuous manufacturing include consistent product quality; smaller equipment; streamlined processes; low process cycle times; reduced operating costs; increased flexibility; elim…								
								 					Article
				
				SEC in the Modern Downstream Purification Process
								The low technical threshold and ease of process development will streamline the manufacturing process so that the barriers to getting a product to market are reduced. Vaccine products generally requir…								
								 					Article
				
				The Bullish Outlook for Biosimilars
								
	Feb 01, 2015 
	
	By Jill E. Sackman, PhD, Michael J. Kuchenreuther, PhD 
	
	BioPharm International 
	
	
	There are several important reasons for stakeholders to be optimistic about prospects for b…								
								 					Article
				
				What Drove Biopharma Development in 2014?
								And while QbD may be a federal requirement, the technique has emerged as a tangible tool to speed time to market, reduce recalls and rejects, minimize post-approval changes, streamline data flows acro…								
								 					Article
				
				New Era for Generic Drugs
								
	Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
	Nov 1, 2014
	
	By: Jill Wechsler
	
	BioPharm International
	
	Volume 11, Issue …								
								 					Article
				
				Viral Clearance Challenges in Bioprocessing
								Comprehensive risk analysis is often effective for highlighting and prioritizing such evaluations to streamline costly virus testing, according to Greenhalgh.
	Process representation
	
	Another chal…								
								 					Article
				
				FDA Seeks Metrics to Define Drug Quality
								An upgraded IT platform could compile information from all sources on sites and products to support a streamlined, risk-based inspection process. This initiative also could evaluate FDA performance, s…								
								 					Article
				
				Operational Excellence: More Than Just Process Improvement
								
	By embracing efficiency and quality, biopharmaceutical organizations can work better and achieve better work.
	Life-sciences companies face more pressure than ever to reduce costs and increase eff…